The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth

Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer

(2020) Yuxiang Li et al.   CELLULAR IMMUNOLOGY

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

(2020) Raffit Hassan et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells

(2020) Elham Masoumi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model

(2020) Yujie Song et al.   CELLULAR IMMUNOLOGY

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

(2019) Ru Zhou et al.   Frontiers in Immunology

CTL-Derived Exosomes Enhance the Activation of CTLs Stimulated by Low-Affinity Peptides

(2019) Shu-Wei Wu et al.   Frontiers in Immunology

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

(2019) Wenyan Fu et al.   Nature Communications

LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1

(2018) Jianli Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here

(2018) Maryann J. Kwa et al.   CANCER

A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers

(2018) Jing Wei et al.   CELLULAR IMMUNOLOGY

Role of T cell-derived exosomes in immunoregulation

(2018) Jian Lu et al.   IMMUNOLOGIC RESEARCH

CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity

(2018) Jing Jie et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity

(2018) Pengxiang Yang et al.   NANO LETTERS

Chimeric Antigen Receptor Therapy

(2018) Carl H. June et al.   NEW ENGLAND JOURNAL OF MEDICINE

CAR T cell immunotherapy for human cancer

(2018) Carl H. June et al.   SCIENCE

Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts

(2018) Daniel Torralba et al.   Nature Communications

Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy

(2018) Ruiwei Guo et al.   Biomaterials Science

The hallmarks of successful anticancer immunotherapy

(2018) Lorenzo Galluzzi et al.   Science Translational Medicine

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

(2017) Carsten Denkert et al.   LANCET

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

(2017) Sattva S. Neelapu et al.   Nature Reviews Clinical Oncology

Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy

(2017) Lisa Rosenbaum   NEW ENGLAND JOURNAL OF MEDICINE

Bioengineering Solutions for Manufacturing Challenges in CAR T Cells

(2017) Nicole J. Piscopo et al.   Biotechnology Journal

Immunotherapy for breast cancer: past, present, and future

(2016) Alison Spellman et al.   CANCER AND METASTASIS REVIEWS

Dendritic cell–derived exosomes for cancer therapy

(2016) Jonathan M. Pitt et al.   JOURNAL OF CLINICAL INVESTIGATION

Immunotherapy in Breast Cancer- Paving New Roads?

(2016) Cristina I. Truica et al.   Current Molecular Pharmacology

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

(2015) A. Morello et al.   Cancer Discovery

Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy

(2015) Xiang-Jun Tang et al.   Oncotarget

Emerging Roles of Exosomes in Normal and Pathological Conditions: New Insights for Diagnosis and Therapeutic Applications

(2015) Julieta De Toro et al.   Frontiers in Immunology

Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers

(2014) C. Alewine et al.   MOLECULAR CANCER THERAPEUTICS

Mesothelin, a novel immunotherapy target for triple negative breast cancer

(2012) Julia Tchou et al.   BREAST CANCER RESEARCH AND TREATMENT

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE